Seeing Value Where Others Saw Risk and How Strategic Conviction Leads to Competitive Advantage: The acquisition of the Swedish biotechnology company Abliva by Pharming On the October 21st 2026, from 14:00–16:00 CEST we invite you to go behind the scenes of Pharming's acquisition of Abliva and gain unique insights from the executives who led this transformative transaction. […]


